We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
-4.39%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$186M
AUM Growth
-$8.68M
Cap. Flow
+$1.69M
Cap. Flow %
0.91%
Top 10 Hldgs %
99.22%
Holding
19
New
1
Increased
1
Reduced
4
Closed
5

Top Buys

Rank Stock Value
1
ESTA icon
Establishment Labs
ESTA
+$70.3M
2
OGI
Organigram Holdings
OGI
+$7.88M

Top Sells

Rank Stock Value
1
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$21.5M
2
CRON
Cronos Group
CRON
+$19.9M
3
ACB
Aurora Cannabis
ACB
+$18M
4
BSTC
BioSpecifics Technologies Corp.
BSTC
+$4.59M
5
ATRS
Antares Pharma, Inc.
ATRS
+$4.46M

Sector Composition

Rank Sector Weight
1 Healthcare 78.05%
2 Consumer Discretionary 18.88%
3 Technology 2.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESTA icon
1
Establishment Labs
ESTA
$2.72B
$68.3M 36.69%
3,104,485
+2,944,485
+1,840% +$70.3M
CGC
2
Canopy Growth
CGC
$375M
$50.2M 26.96%
124,120
-5,000
-4% -$2.2M
AMZN icon
3
Amazon
AMZN
$2.5T
$35.1M 18.88%
371,040
-21,500
-5% -$2M
OGI
4
Organigram Holdings
OGI
$132M
$7.31M 3.93%
+283,800
New +$7.88M
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$6.51M 3.5%
270,775
– –
MSFT icon
6
Microsoft
MSFT
$2.84T
$5.56M 2.99%
41,500
– –
PETQ
7
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$4.91M 2.64%
148,855
– –
CTST
8
DELISTED
CannTrust Holdings Inc. Common Share
CTST
$4.24M 2.28%
843,909
-556,000
-40% -$3.4M
AVDL
9
DELISTED
Avadel Pharmaceuticals
AVDL
$1.28M 0.69%
444,439
– –
ATRS
10
DELISTED
Antares Pharma, Inc.
ATRS
$1.25M 0.67%
380,524
-1,540,000
-80% -$4.46M
RVLP
11
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$855K 0.46%
225,000
– –
ALIM
12
DELISTED
Alimera Sciences
ALIM
$368K 0.2%
27,553
– –
APHA
13
DELISTED
Aphria Inc. Common Shares
APHA
$145K 0.08%
20,636
– –
HEXO
14
DELISTED
HEXO Corp. Common Shares
HEXO
$80K 0.04%
268
– –
ACB
15
Aurora Cannabis
ACB
$165M
– –
-16,605
Closed -$18M
CRON
16
Cronos Group
CRON
$1.05B
– –
-1,081,444
Closed -$19.9M
EGRX
17
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-425,755
Closed -$21.5M
BSTC
18
DELISTED
BioSpecifics Technologies Corp.
BSTC
– –
-73,649
Closed -$4.59M
NVLN
19
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
– –
-315,979
Closed -$389K

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
BB
Burford Brothers Dallas, Texas $244M AUM 24.94% 1-Year Est. Return
QHA
Quarry Hill Advisors St Paul, Minnesota $243M AUM 24.02% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return

JW Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, JW Asset Management held 19 positions worth $186M, down 4.5% from $195M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

JW Asset Management's Q2 2019 filing shows 1 new, 1 increased, 4 reduced and 5 closed positions. Its largest new stake was Organigram Holdings: 283,800 shares worth $7.31M. The largest sale was Eagle Pharmaceuticals, Inc., an estimated $21.5M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 79% a quarter earlier, followed by Consumer Discretionary and Technology.

  • JW Asset Management's largest Q2 2019 buy was Organigram Holdings: 283,800 shares worth $7.31M.
  • JW Asset Management added most to Establishment Labs in Q2 2019, an estimated $70.3M increase.
  • JW Asset Management's biggest Q2 2019 reduction was Antares Pharma, Inc., cutting an estimated $4.46M.
  • JW Asset Management fully exited Eagle Pharmaceuticals, Inc. in Q2 2019, selling an estimated $21.5M.
  • JW Asset Management's ten largest holdings make up 99% of its $186M portfolio in Q2 2019.
  • JW Asset Management opened 1 new position and closed 5 in Q2 2019.
  • JW Asset Management's portfolio value fell 4.5% quarter-over-quarter to $186M.

Based on JW Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.